The diabetes vaccine offers hopeful results in mice
The researchers at the University of Pittsburgh (United States) who are developing an experimental vaccine for diabetes have managed to prevent this disease in mice by slowing their initial appearance in immune system cells.
As explained by the main author of the investigation, Nick Giannoukakis, with only an injected dose of that vaccine have managed to delay the appearance of diabetes while, applying eight doses, it was possible to avoid the disease totally.
However, despite these results, researchers have not wanted to launch a halo of hope and assured that their application in humans will not be able to reverse "more than 5 years" diabetes.
Other research in mice with a high level of blood sugar have already demonstrated that the dose of the vaccine twice a week for a maximum of 25 days could invest the start of hyperglycemia and maintain normal levels after the interruption of the vaccine.
It is expected that the safety of the vaccine will be tested in volunteer patients with type 1 diabetes when they finish the rest of the studies that are being performed and, once their safety is confirmed, it could begin to be administered in these patients with the newly diagnosed disease."The idea is that at the end of 2010 or early 2011 we can start distributing it," Giannoukakis explained.
